• OPEN AN ACCOUNT
Indian Indices
Nifty
24,946.50 227.90
(0.92%)
Sensex
81,535.10 -261.05
( -0.32%)
Bank Nifty
55,944.90 417.55
( 0.75%)
Nifty IT
39,073.05 603.80
( 1.57%)
Global Indices
Nasdaq
42,540.48 321.68
(0.76%)
Dow Jones
6,054.14 56.17
(0.94%)
Hang Seng
38,529.66 218.33
(0.57%)
Nikkei 225
8,875.22 24.59
(0.28%)
Forex
USD-INR
85.72 0.17
(0.19%)
EUR-INR
98.97 0.08
(0.08%)
GBP-INR
116.32 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
94.43
404419.91
EPS(TTM)
Face Value()
Div & Yield %
17.85
1
0.95
 

srg fingrow finance ltd
Tata Motors Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Apr 24,2025
Pursuant to Regulation 30 read with Schedule III of Part A of para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and with further reference to our letter bearing sc no. 18646 dated April 18 2025 we wish to inform you that the Company will hold an investor / analyst conference call on Tuesday May 13 2025 at 6:30 p.m. (IST). During the call the Senior Management of the Company and Jaguar Land Rover Limited (Wholly Owned Subsidiary) will discuss on the financial results and operations for the quarter ended March 31 2025.